Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 14, 2017; 23(26): 4796-4805
Published online Jul 14, 2017. doi: 10.3748/wjg.v23.i26.4796
Table 5 Characteristics of markers in active and inactive Crohn’s disease groups and controls
Crohn’s disease inactiveCrohn’s disease activeControl group
n = 16n = 22n = 50
VWF:RCo, IU/dL143.47 ± 46.12157.04 ± 61.03a114.03 ± 24.67
VWF:Ag, IU/dL135.4 (116.85-175.65)a182.98 (130.4-219.8)a106.65 (90.7-122.5)
VWF:CB, IU/dL98.85 (86.15-102.25)89.3 (80.6-99.7)98.05 (91.9-101.8)
ADAMTS13:Ag, IU/dL104.44 ± 9.9699.29 ± 15.33103.86 ± 10.84
ADAMTS13act, IU/dL104.82 ± 8.6194.48 ± 15.74a111.05 ± 17.69
VWFRCo/VWF:Ag0.96 (0.95-1.00)0.96 (0.79-1.01)0.97 (0.91-1.15)
VWF:CB/VWF:Ag0.65 (0.45-0.87)a0.54 (0.45-0.65)a0.91 (0.80-1.05)
VWF:Ag/ADAMTS13act1.26 (1.12-1.62)a1.88 (1.48-2.56)a0.98 (0.79-1.20)
ADAMTS13act/ADAMTS13:Ag0.99 (0.94-1.05)0.96 (0.92-1.03)1.02 (0.94-1.18)